Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1921–1944 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Parkinson's Disease
Interventions: Amantadine 300 mg, Topiramate, Sugar Pill; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cognitive Impairment, Dementia
Interventions: No interventions; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 60 Years to 90 Years
Enrollment: 1,892 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 17
States / cities: Los Angeles, California • Sacramento, California • San Francisco, California + 12 more

Conditions: mHealth, Adherence, Patient
Interventions: Interview; Other
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Not listed
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Healthy
Interventions: Diclofenac Sodium Gel; Drug
Lead sponsor: Amzell; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Knee Osteoarthritis, Knee Arthritis, Knee Pain Chronic, Knee Deformity, Knee Pain Swelling, Muscle Weakness, Muscle Weakness Condition, Power
Interventions: Manual Physical Therapy; Procedure
Lead sponsor: Jennifer Moreno Clinic; Other
Eligibility: 45 Years to 74 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier, Glioblastoma, Lymphoma, Primary Central Nervous System Lymphoma
Interventions: CC-122; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 17
States / cities: Duarte, California • Los Angeles, California • San Francisco, California + 13 more

Conditions: Conjunctivitis, Adenoviral Conjunctivitis
Interventions: Betadine 5%, Artificial Tears; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Low Back Pain
Interventions: PPP treatment, PRP treatment, PRP and PL Combo treatment; Biological
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Broomfield, Colorado • Lone Tree, Colorado

Conditions: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Interventions: Mosunetuzumab, Tocilizumab, Venetoclax, Rituximab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 332 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 5
States / cities: Rochester, Minnesota • New York, New York • Columbus, Ohio + 2 more

Conditions: Psoriasis
Interventions: Group #2 (Intervention), Group #3 (Intervention); Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Depressive Disorder
Interventions: Star*D algorithm, rEEG-guided therapy; Other
Lead sponsor: MYnd Analytics; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 13
States / cities: Glendale, California • Irvine, California • San Bernardino, California + 10 more

Conditions: Melanoma (Skin Cancer)
Interventions: Improve awareness of checking moles, Comparator; Behavioral · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 560 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Esophageal Cancer, Gastric Cancer
Interventions: irinotecan hydrochloride, paclitaxel; Drug
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2005
U.S. locations: 4
States / cities: Los Angeles, California • Chicago, Illinois • Portland, Oregon

Conditions: Diabetes, Depression
Interventions: Beating the Blues, Escitalopram, Placebo; Behavioral · Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 81 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Parkinson Disease
Interventions: Immediate treatment, Deferred treatment; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer's Disease
Interventions: MRI, MR Spectroscopy, MR Perfusion; Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 45 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Low Back Pain
Interventions: Acetaminophen, Ibuprofen 600 mg, Educational intervention, Placebo oral capsule; Drug · Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 69 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Kidney Injury
Interventions: 0.9% Sodium Chloride (Placebo), Sodium Bicarbonate; Drug
Lead sponsor: Community Medical Center, Scranton, PA; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Brain Metastases
Interventions: Stereotactic Radiosurgery; Radiation
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Smoking Cessation
Interventions: Naltrexone (Vivitrol), Bupropion; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson's Disease
Interventions: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus; Genetic
Lead sponsor: Neurologix, Inc.; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 7
States / cities: Stanford, California • Aurora, Colorado • Boston, Massachusetts + 4 more

Conditions: ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Interventions: Galunisertib 150mg by mouth twice a day, Stereotactic Body Radiotherapy (SBRT); Drug · Radiation
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Nonalcoholic Steatohepatitis
Interventions: Erchonia Verju Laser, Erchonia EVRL Laser; Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Prescription Drug Abuse (Not Dependent)
Interventions: Oxycodone Medication First, Placebo First; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study

Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants

Rate of Torque Development and Voluntary Quadriceps Activation in Patients With Knee Osteoarthritis: A Quantitative Analysis Before and After a Single Session of Manual Physical Therapy

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Reducing Adenoviral Patient Infected Days

A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis

rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure

Promoting Early Detection of Melanoma During the Mammography Experience

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

Depression-Diabetes Mechanisms: Urban African Americans

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study

Ibuprofen With or Without Acetaminophen for Low Back Pain

Prevention of Acute Kidney Injury in Cardiac Surgery Patients

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

A Study to See if Low Level Laser Light Therapy (LLLT) Can Improve the Condition of Nonalcoholic Steatohepatitis (NASH)

Influence of Medication on Functional Connectivity